期刊
KIDNEY INTERNATIONAL
卷 72, 期 8, 页码 985-993出版社
ELSEVIER SCIENCE INC
DOI: 10.1038/sj.ki.5002467
关键词
biomarkers; cadmium; Kim-1; nephrotoxicity; Clara cell protein (CC-16); metallothionein
资金
- Intramural NIH HHS Funding Source: Medline
- NIDDK NIH HHS [R33 DK074099, R01 DK072381, DK 074099, R37 DK039773, DK072831, R21 DK074099, R01 DK039773, DK 039773] Funding Source: Medline
- NIEHS NIH HHS [ES 006478, R00 ES016723, R01 ES006478, R00 ES016723-02] Funding Source: Medline
Cadmium ( Cd) exposure results in injury to the proximal tubule characterized by polyuria and proteinuria. Kidney injury molecule-1 ( Kim-1) is a transmembrane glycoprotein not normally detected in the mature kidney, but is upregulated and shed into the urine following nephrotoxic injury. In this study, we determine if Kim-1 might be a useful early biomarker of Cd nephrotoxicity. Male Sprague-Dawley rats were given daily injections of Cd for up to 12 weeks. Weekly urine samples were analyzed for Kim-1, protein, creatinine, metallothionein, and Clara cell protein CC-16. Significant levels of Kim-1 were detected in the urine by 6 weeks and continued to increase throughout the treatment period. This appearance of Kim-1 occurred 4-5 weeks before the onset of proteinuria, and 1-3 weeks before the appearance of metallothionein and CC-16. Higher doses of Cd gave rise to higher Kim-1 excretion. Reverse transcriptase-polymerase chain reaction ( RT-PCR) expression analysis showed that Kim-1 transcript levels were increased after 6 weeks at the low dose of Cd. Immunohistochemical analysis showed that Kim-1 was present in proximal tubule cells of the Cd-treated rats. Our results suggest that Kim-1 may be a useful biomarker of early stages of Cd-induced proximal tubule injury.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据